EcoDrugPlus

Opioid Receptor, Delta 1b

Ensembl ID : ENSCHAG00000011370
Gene Symbol: OPRD1B
1 Cross references
138 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSCHAG00000003196
Gene Symbol: OPRK1
1 Cross references
200 Possible Orthologues:

Opioid Related Nociceptin Receptor 1

Ensembl ID : ENSCHAG00000008183
Gene Symbol: OPRL1
1 Cross references
132 Possible Orthologues:

Orexin Receptor Type 2-Like

Ensembl ID : ENSCHAG00000017187
Gene Symbol: LOC105911532
3 Cross references
201 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSCHAG00000009498
Gene Symbol: OXTR
3 Cross references
193 Possible Orthologues:

Oxytocin Receptor B

Ensembl ID : ENSCHAG00000025141
Gene Symbol: OXTRB
1 Cross references
136 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSCHAG00000015972
Gene Symbol: PTH1R
3 Cross references
198 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSCHAG00000006045
Gene Symbol: PPARD
3 Cross references
352 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSCHAG00000015643
Gene Symbol: PPARG
1 Cross references
390 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha B

Ensembl ID : ENSCHAG00000010950
Gene Symbol: PPARAB
1 Cross references
397 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Delta B

Ensembl ID : ENSCHAG00000014206
Gene Symbol: PPARDB
1 Cross references
392 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSCHAG00000008193
Gene Symbol: PIK3CA
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).